Squarepoint Ops LLC Collegium Pharmaceutical, Inc Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 39,555 shares of COLL stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,555

Previous 122,473 67.7%

Holding current value

$1.15 Million

Previous $4.73 Million 76.06%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$28.61 - $41.86 $2.37 Million - $3.47 Million	-82,918 Reduced 67.7%	39,555 $1.13 Million
Q3 2024 Nov 14, 2024	BUY	$31.4 - $39.07 $381,039 - $474,114	12,135 Added 11.0%	122,473 $4.73 Million
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $2.29 Million - $2.91 Million	72,874 Added 194.52%	110,338 $3.55 Million
Q1 2024 May 15, 2024	SELL	$31.23 - $40.91 $39,724 - $52,037	-1,272 Reduced 3.28%	37,464 $1.45 Million
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $284,580 - $414,229	13,449 Added 53.19%	38,736 $1.19 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $532,544 - $606,888	25,287 New	25,287 $543,000
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $526,097 - $772,497	-36,997 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $380,257 - $497,430	22,108 Added 148.49%	36,997 $753,000
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $260,557 - $317,880	14,889 New	14,889 $278,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $516,454 - $738,747	-29,096 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $394,515 - $458,756	18,147 Added 165.74%	29,096 $688,000
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $210,768 - $285,768	10,949 New	10,949 $259,000
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $195,131 - $243,941	-10,944 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $115,462 - $152,339	-7,317 Reduced 40.07%	10,944 $228,000
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $240,668 - $365,274	-15,537 Reduced 45.97%	18,261 $320,000
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $479,788 - $879,093	-34,542 Reduced 50.54%	33,798 $552,000
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $149,553 - $310,848	-13,977 Reduced 16.98%	68,340 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $49,204 - $64,315	4,843 Added 6.25%	82,317 $945,000
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $293,250 - $458,099	27,613 Added 55.38%	77,474 $1.02 Million
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $430,825 - $593,892	31,725 Added 174.93%	49,861 $755,000
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $499,031 - $664,475	-33,764 Reduced 65.06%	18,136 $311,000
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $256,296 - $439,830	18,100 Added 53.55%	51,900 $765,000
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $372,434 - $483,532	17,092 Added 102.3%	33,800 $806,000
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $170,374 - $274,194	-9,387 Reduced 35.97%	16,708 $427,000
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $242,683 - $499,458	26,095	26,095 $482,000

Others Institutions Holding COLL

# of Institutions

247

Shares Held

37.4M

Call Options Held

59.3K

Put Options Held

9.5K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $991M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Collegium Pharmaceutical, Inc Transaction History